Highline Vision Center & Highline Center For Vision Performance
720-870-2828

Essilor Stellest Lenses

Benefits of Essilor® Stellest® lenses

Slowed myopia progression by 71% on average over 2 years1 2 

Correct myopia with single vision zone to ensure sharp vision

An easy to use and proven1 2 way to help manage your child’s nearsightedness

Don’t just correct myopia – slow the progression

Essilor® Stellest® lenses are Essilor®’s breakthrough3 innovation to slow myopia progression in children. Essilor® Stellest® lenses are the first and only FDA market authorized spectacle lens to slow the progression of nearsightedness in children1 2.

Our Hours

  • Monday
  • 8:00 AM - 5:00 PM
  • Tuesday
  • 8:00 AM - 5:00 PM
  • Wednesday
  • 9:00 AM - 5:00 PM
  • Thursday
  • 8:00 AM - 5:00 PM
  • Friday
  • 8:00 AM - 5:00 PM
  • Saturday
  • Closed - Closed
  • Sunday
  • Closed - Closed

Why choose Essilor® Stellest® lenses for your child?

Essilor® Stellest® lenses slowed myopia progression by 71% on average over 2 years1 2 

Experience the Essilor® Stellest® lens difference

Essilor® Stellest® lenses are designed with 2 ingeniously complementary parts that, when combined, have a powerful effect.

Correct
Bringing sharp vision with your child’s prescription



Control
Slow myopia progression with H.A.L.T.4 technology

Is Essilor® Stellest® the right lens for my child?

The younger a child develops nearsightedness, the further it evolves and the stronger it becomes. You can correct and slow your child’s myopia progression with Essilor® Stellest® lenses.

Today, most myopic children wear standard ophthalmic lenses, which only correct nearsightedness. Essilor® Stellest® lenses not only correct myopia but also slow its progression.

  1. 1. Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment.
  2. 2. Essilor International, data on file (2025).
  3. 3. Compared to single vision lenses. Results from a prospective, randomized, double-masked, multicenter U.S. clinical trial in myopic children aged 6–12 years at initiation of treatment.
  4. 4. H.A.L.T. is an acronym for Highly Aspherical Lenslet Target and does not imply a “halt” or “stop” of myopia progression.

View All Of Our Eye Care Services

The team of doctors at Highline Vision Center in Aurora, Colorado are friendly, professional, and focused on care.

Request an appointment with our office today!